Nearly three-quarters (74%) of emergency department patients consider diagnosis with CT more important than any associated radiation risk, according to a survey at Thomas Jefferson University Hospital in Philadelphia.
Nearly three-quarters (74%) of emergency department patients consider diagnosis with CT more important than any associated radiation risk, according to a survey at Thomas Jefferson University Hospital in Philadelphia. However, more than two-thirds (68%) of patients prefer the ordering physician to discuss the risks and benefits of CT with them before ordering the test.
The survey included 383 emergency department patients. Seventy-nine percent of patients correctly estimated their risk of cancer from chest x-rays as none, small, or very small. Eighty-three percent correctly estimated their risk of cancer from CT scans as none, small, or very small.
The researchers found differences in knowledge of radiation stratified by age, race, education, insurance status, and pain.
“Our results suggest we may help emergency department patients better with targeted teaching about radiation, decreasing their pain, discussing risks and benefits, and asking them to participate in the ordering of their diagnostic tests,” the authors said.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.